Sight Sciences Inc SGHT.OQ SGHT.O is expected to show a rise in quarterly revenue when it reports results on March 5 for the period ending December 31 2024
The Menlo Park California-based company is expected to report a 6.3% increase in revenue to $19.924 million from $18.75 million a year ago, according to the mean estimate from 7 analysts, based on LSEG data.
LSEG's mean analyst estimate for Sight Sciences Inc is for a loss of 20 cents per share.
The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 2 "strong buy" or "buy," 6 "hold" and no "sell" or "strong sell."
The mean earnings estimate of analysts was unchanged in the last three months.
Wall Street's median 12-month price target for Sight Sciences Inc is $4.80, above its last closing price of $2.65.
Previous quarterly performance (using preferred earnings measure in US dollars).
QUARTER ENDING
STARMINESMARTESTIMATE®
LSEG IBES ESTIMATE
ACTUAL
BEAT, MET, MISSED
SURPRISE %
Sep. 30 2024
-0.22
-0.21
-0.22
Missed
-6
Jun. 30 2024
-0.30
-0.30
-0.25
Beat
15.5
Mar. 31 2024
-0.26
-0.28
-0.33
Missed
-19.7
Dec. 31 2023
-0.30
-0.32
-0.22
Beat
30.6
Sep. 30 2023
-0.31
-0.32
-0.27
Beat
15
Jun. 30 2023
-0.34
-0.34
-0.30
Beat
12.1
Mar. 31 2023
-0.40
-0.39
-0.35
Beat
10.7
Dec. 31 2022
-0.43
-0.42
-0.35
Beat
16.1
This summary was machine generated March 3 at 21:40 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)